Fanciullacci A, Cappetti P, Ciaccio B, Caponi A, Bartoli P, Taviani R, Berti P
Quad Sclavo Diagn. 1984 Dec;20(4):355-63.
On the basis of more than 3,000 tests carried out on 1,561 patients suffering from suspected or certain malignant tumours, the authors established the necessity of CEA test in post-operative follow-ups, according to the plentiful literature regarding this matter. New tumoral markers led the authors to verify if it was useful to associate the ferritin to CEA test. From the results and the statistical data, they concluded that it was useful to associate the two markers only in negative CEA test when confronted with clinical suspected metastatic diffusion.
基于对1561例疑似或确诊恶性肿瘤患者进行的3000多次检测，作者根据关于此事的大量文献，确定了癌胚抗原（CEA）检测在术后随访中的必要性。新的肿瘤标志物促使作者去验证将铁蛋白与CEA检测联合使用是否有用。从结果和统计数据来看，他们得出结论，在面对临床疑似转移扩散且CEA检测呈阴性时，将这两种标志物联合使用是有用的。
